Researchers at the University of California, Riverside, proposed a new RNA-based vaccine they said could provide durable protection for infants against COVID-19 and flu with just one dose. Experts warn the untested technology could lead to breakthrough infections, higher mortality rates and potential brain toxicity in babies.